These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 5492474)

  • 1. Absorption and excretion of 35S dapsone in dermatitis herpetiformis.
    Alexander JO; Young E; McFadyen T; Fraser NG; Duguid WP; Meredith EM
    Br J Dermatol; 1970 Dec; 83(6):620-31. PubMed ID: 5492474
    [No Abstract]   [Full Text] [Related]  

  • 2. Dermatitis herpetiformis. The role of gluten.
    Marks J; Shuster S
    Arch Dermatol; 1970 Apr; 101(4):452-7. PubMed ID: 5443952
    [No Abstract]   [Full Text] [Related]  

  • 3. Dapsone for treatment of pruritic dermatitis (dermatitis herpetiformis and subcorneal pustular dermatosis) in dogs.
    Halliwell RE; Schwartzman RM; Ihrke PJ; Goldschmidt MH; Wood MG
    J Am Vet Med Assoc; 1977 Apr; 170(7):697-703. PubMed ID: 858685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism and haemolytic effect of dapsone and its metabolites in man.
    Halmekoski J; Mattila MJ; Mustakallio KK
    Med Biol; 1978 Aug; 56(4):216-21. PubMed ID: 703406
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of ibuprofen on serum dapsone levels and disease activity in dermatitis herpetiformis.
    Smith JB; Fowler JB; Zone JJ
    Arch Dermatol; 1994 Feb; 130(2):257-9. PubMed ID: 8304772
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapeutic use of dapsone in dermatitis herpetiformis (Duhring) and in certain inflammatory skin diseases].
    Révész K; Schneider I
    Orv Hetil; 1995 Jan; 136(2):59-62. PubMed ID: 7862431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between dapsone dose, serum concentration and disease severity in dermatitis herpetiformis.
    Sanders SW; Zone JJ
    Arzneimittelforschung; 1986; 36(1):146-9. PubMed ID: 3954818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The absorption of dapsone by patients with dermatitis herpetiformis and coeliac disease.
    Wright JT; Das AK
    Clin Exp Dermatol; 1980 Mar; 5(1):27-30. PubMed ID: 7398122
    [No Abstract]   [Full Text] [Related]  

  • 9. The ultrastructural changes in the skin in dermatitis herpetiformis after withdrawal of dapsone.
    Riches DJ; Martin BG; Seah PP; Fry L
    Br J Dermatol; 1976 Jan; 94(1):31-7. PubMed ID: 1252338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Agranulocytosis induced by dapsone prescribed for dermatitis herpetiformis].
    Machet L; Callens A; Mercier E; Gargot S; Lorette G; Vaillant L
    Ann Dermatol Venereol; 1996; 123(5):328-30. PubMed ID: 8761086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dapsone acetylation in dermatitis herpetiformis.
    Ellard GA; Gammon PT; Savin JA; Tan RS
    Br J Dermatol; 1974 Apr; 90(4):441-4. PubMed ID: 4823883
    [No Abstract]   [Full Text] [Related]  

  • 12. Dermatitis herpetiformis--a disease associated with intestinal malabsorption.
    Johnson DP; Alpert ME
    Am J Gastroenterol; 1971 Jan; 55(1):21-32. PubMed ID: 5573149
    [No Abstract]   [Full Text] [Related]  

  • 13. Dapsone in dermatitis herpetiformis and other immunological diseases.
    Dahl MG
    Lancet; 1977 Feb; 1(8008):429. PubMed ID: 65542
    [No Abstract]   [Full Text] [Related]  

  • 14. [Management of dermatitis herpetiformis].
    Schuppli R
    Dtsch Med Wochenschr; 1968 Nov; 93(48):2343. PubMed ID: 4301398
    [No Abstract]   [Full Text] [Related]  

  • 15. The incidence of agranulocytosis during treatment of dermatitis herpetiformis with dapsone as reported in Sweden, 1972 through 1988.
    Hörnsten P; Keisu M; Wiholm BE
    Arch Dermatol; 1990 Jul; 126(7):919-22. PubMed ID: 2360840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral acantholytic itching disease responding to dapsone. Dermatitis herpetiformis, pemphigus, or a new disease?
    Lindgren S; Enerbäck L; Freiberg N
    Oral Surg Oral Med Oral Pathol; 1976 Nov; 42(5):597-605. PubMed ID: 1068417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of dapsone and gluten-free diet on the immune complexes in the skin of patients with dermatitis herpetiformis [proceedings].
    van der Meer JB; Poen H; van der Putte SC; Nefkens MJ; Baart de la Faille-Kuyper EH
    Br J Dermatol; 1979 Aug; 101(2):232-3. PubMed ID: 486336
    [No Abstract]   [Full Text] [Related]  

  • 18. Dermatitis herpetiformis: consequences of elemental diet.
    Zeedijk N; van der Meer JB; Poen H; van der Putte SC
    Acta Derm Venereol; 1986; 66(4):316-20. PubMed ID: 2430402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discontinuing dapsone treatment and reintroducing dietary gluten in patients with dermatitis herpetiformis in remission: comment on "remission in dermatitis herpetiformis".
    Mostow EN
    Arch Dermatol; 2011 Mar; 147(3):305-6. PubMed ID: 21422338
    [No Abstract]   [Full Text] [Related]  

  • 20. Possible dapsone-induced peripheral neuropathy in dermatitis herpetiformis.
    du Vivier A; Fowler T
    Proc R Soc Med; 1974 Jun; 67(6 Pt 1):439-40. PubMed ID: 4369028
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.